Advanced search
Publication Cover
Pharmacogenomics Volume 12, 2011 - Issue 2
Submit an article Journal homepage
684
Views
0
CrossRef citations to date
0
Altmetric
Review

Transcriptional Profiling to Identify Biomarkers of Disease and Drug Response

Donna L MendrickDivision of Systems Biology, HFT-230, National Center for Toxicological Research, US FDA, 3900 NCTR Rd, Jefferson, AR72079-4502, USA. Tel.: +1 870 543 7718 Fax: +1 870 543 [email protected]
Pages 235-249 | Published online: 18 Feb 2011

Bibliography

  • Mendrick DL , DanielsKK: Biomarkers of drug-induced adverse events.Expert Rev. Clin. Pharmacol.1 , 81–91 (2008).
  • Marchionni L , WilsonRF, WolffAC et al.: Systematic review: gene expression profiling assays in early-stage breast cancer.Ann. Intern. Med.148 , 358–369 (2008).
  • Liew CC , MaJ, TangHC, ZhengR, DempseyAA: The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool.J. Lab. Clin. Med.147 , 126–132 (2006).
  • Powell EE , KroonPA: Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.J. Clin. Invest.93 , 2168–2174 (1994).
  • Aggarwal D , FreakeHC, SolimanGA, DuttaA, FernandezML: Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism.Lipids Health Dis.5 , 22 (2006).
  • Guan JZ , TamasawaN, MurakamiH et al.: HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in Type 2 diabetic patients with hyperlipidemia.J. Atheroscler. Thromb.15 , 20–25 (2008).
  • Mikael LG , RozenR: Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-κB/iNOS.Cardiovasc. Res.80 , 151–158 (2008).
  • Pham MX , TeutebergJJ, KfouryAG et al.: Gene-expression profiling for rejection surveillance after cardiac transplantation.N. Engl. J. Med.362(20) , 1890–1900 (2010).
  • Burczynski ME , DornerAJ: Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.Pharmacogenomics7 , 187–202 (2006).
  • Tang Y , LuA, AronowBJ, SharpFR: Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease.Ann. Neurol.50 , 699–707 (2001).
  • Tang Y , NeeAC, LuA, RanR, SharpFR: Blood genomic expression profile for neuronal injury.J. Cereb. Blood Flow Metab.23 , 310–319 (2003).
  • Du X , TangY, XuH et al.: Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine and Tourette syndrome.Genomics87 , 693–703 (2006).
  • Tang Y , XuH, DuX et al.: Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.J. Cereb. Blood Flow Metab.26 , 1089–1102 (2006).
  • Xu H , TangY, LiuDZ et al.: Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke.J. Cereb. Blood Flow Metab.28 , 1320–1328 (2008).
  • Lovrecic L , KastrinA, KobalJ, PirtosekZ, KraincD, PeterlinB: Gene expression changes in blood as a putative biomarker for Huntington‘s disease.Mov. Disord.24 , 2277–2281 (2009).
  • Wong B , GilbertDL, WalkerWL et al.: Gene expression in blood of subjects with Duchenne muscular dystrophy.Neurogenetics10 , 117–125 (2009).
  • Borovecki F , LovrecicL, ZhouJ et al.: Genome-wide expression profiling of human blood reveals biomarkers for Huntington‘s disease.Proc. Natl Acad. Sci. USA102 , 11023–11028 (2005).
  • Runne H , KuhnA, WildEJ et al.: Analysis of potential transcriptomic biomarkers for Huntington‘s disease in peripheral blood.Proc. Natl Acad. Sci. USA104 , 14424–14429 (2007).
  • Scherzer CR , EklundAC, MorseLJ et al.: Molecular markers of early Parkinson‘s disease based on gene expression in blood.Proc. Natl Acad. Sci. USA104 , 955–960 (2007).
  • Bowden NA , WeidenhoferJ, ScottRJ et al.: Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia.Schizophr. Res.82 , 175–183 (2006).
  • Takahashi M , HayashiH, WatanabeY et al.: Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures.Schizophr. Res.119 , 210–218 (2010).
  • Tang Y , GlauserTA, GilbertDL et al.: Valproic acid blood genomic expression patterns in children with epilepsy – a pilot study.Acta Neurol. Scand.109 , 159–168 (2004).
  • Le Niculescu H , KurianSM, YehyawiN et al.: Identifying blood biomarkers for mood disorders using convergent functional genomics.Mol. Psychiatry14(2) , 156–174 (2008).
  • Ogden CA , RichME, SchorkNJ et al.: Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.Mol. Psychiatry9 , 1007–1029 (2004).
  • Kurian SM , Le-NiculescuH, PatelSD et al.: Identification of blood biomarkers for psychosis using convergent functional genomics.Mol. Psychiatry16(1) , 37–58 (2011).
  • Burczynski ME , PetersonRL, TwineNC et al.: Molecular classification of Crohn‘s disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.J. Mol. Diagn.8 , 51–61 (2006).
  • Knowlton N , JiangK, FrankMB et al.: The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states.Arthritis Rheum.60 , 892–900 (2009).
  • Griffin TA , BarnesMG, IlowiteNT et al.: Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.Arthritis Rheum.60 , 2113–2123 (2009).
  • Mesko B , PoliskaS, SzegediA et al.: Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets.BMC Med. Genomics3 , 15 (2010).
  • Sinnaeve PR , DonahueMP, GrassP et al.: Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.PLoS ONE4 , e7037 (2009).
  • Wingrove JA , DanielsSE, SehnertAJ et al.: Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis.Circ. Cardiovasc. Genet.1 , 31–38 (2008).
  • Camargo A , RuanoJ, FernandezJM et al.: Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil.BMC Genomics11 , 253 (2010).
  • Hermsdorff HH , ZuletMA, PuchauB, MartinezJA: Fruit and vegetable consumption and proinflammatory gene expression from peripheral blood mononuclear cells in young adults: a translational study.Nutr. Metab. (Lond.)7 , 42 (2010).
  • Radom-Aizik S , ZaldivarF Jr, Leu SY, Galassetti P, Cooper DM: Effects of 30 min of aerobic exercise on gene expression in human neutrophils. J. Appl. Physiol.104 , 236–243 (2008).
  • Radom-Aizik S , ZaldivarF Jr, Leu SY, Cooper DM: Brief bout of exercise alters gene expression in peripheral blood mononuclear cells of early- and late-pubertal males. Pediatr. Res.65 , 447–452 (2009).
  • Radom-Aizik S , ZaldivarF Jr, Leu SY, Cooper DM: A brief bout of exercise alters gene expression and distinct gene pathways in peripheral blood mononuclear cells of early- and late-pubertal females. J. Appl. Physiol.107 , 168–175 (2009).
  • Hayashi Y , KajimotoK, IidaS et al.: DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting Type 2 diabetes.Biol. Pharm. Bull.33 , 1033–1042 (2010).
  • Takamura T , HondaM, SakaiY et al.: Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of Type 2 diabetes.Biochem. Biophys. Res. Commun.361 , 379–384 (2007).
  • Huang H , DongX, KangMX et al.: Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles.Am. J. Gastroenterol.105 , 1661–1669 (2010).
  • Bushel PR , HeinlothAN, LiJ et al.: Blood gene expression signatures predict exposure levels.Proc. Natl Acad. Sci. USA104 , 18211–18216 (2007).
  • Lobenhofer EK , AumanJT, BlackshearPE et al.: Gene expression response in target organ and whole blood varies as a function of target organ injury phenotype.Genome Biol.9 , R100 (2008).
  • Huang J , ShiW, ZhangJ et al.: Genomic indicators in the blood predict drug-induced liver injury.Pharmacogenomics J.10 , 267–277 (2010).
  • Wetmore BA , BreesDJ, SinghR et al.: Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury.Hepatology51 , 2127–2139 (2010).
  • O‘Toole M , JanszenDB, SlonimDK et al.: Risk factors associated with β-amyloid(1–42) immunotherapy in preimmunization gene expression patterns of blood cells.Arch. Neurol.62 , 1531–1536 (2005).
  • Yun JW , LeeTR, KimCW et al.: Predose blood gene expression profiles might identify the individuals susceptible to carbon tetrachloride-induced hepatotoxicity.Toxicol. Sci.115 , 12–21 (2010).
  • Yun JW , KimCW, BaeIH et al.: Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure.Toxicol. Appl. Pharmacol.239 , 55–63 (2009).
  • Thum T , CatalucciD, BauersachsJ: MicroRNAs: novel regulators in cardiac development and disease.Cardiovasc. Res.79 , 562–570 (2008).
  • Cortez MA , CalinGA: MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.Expert Opin. Biol. Ther.9 , 703–711 (2009).
  • van Rooij E , QuiatD, JohnsonBA et al.: A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.Dev. Cell17 , 662–673 (2009).
  • Fichtlscherer S , DeRS, FoxH et al.: Circulating microRNAs in patients with coronary artery disease.Circ. Res.107 , 677–684 (2010).
  • Liang M , LiuY, MladinovD et al.: MicroRNA: a new frontier in kidney and blood pressure research.Am. J. Physiol. Renal Physiol.297 , F553–F558 (2009).
  • Ryan BM , RoblesAI, HarrisCC: Genetic variation in microRNA networks: the implications for cancer research.Nat. Rev. Cancer10 , 389–402 (2010).
  • Linsen SE , de Wit E, de Bruijn E, Cuppen E: Small RNA expression and strain specificity in the rat. BMC Genomics11 , 249 (2010).
  • Olena AF , PattonJG: Genomic organization of microRNAs.J. Cell. Physiol.222 , 540–545 (2010).
  • Wittmann J , Jack HM: Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta1806(2) , 200–207 (2010).
  • Liu DZ , TianY, AnderBP et al.: Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures.J. Cereb. Blood Flow Metab.30 , 92–101 (2010).
  • Cox MB , CairnsMJ, GandhiKS et al.: MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.PLoS ONE5 , e12132 (2010).
  • Wang K , ZhangS, MarzolfB et al.: Circulating microRNAs, potential biomarkers for drug-induced liver injury.Proc. Natl Acad. Sci. USA106 , 4402–4407 (2009).
  • Ji X , TakahashiR, HiuraY, HirokawaG, FukushimaY, IwaiN: Plasma miR-208 as a biomarker of myocardial injury.Clin. Chem.55 , 1944–1949 (2009).
  • van Rooij E , SutherlandLB, QiX, RichardsonJA, HillJ, OlsonEN: Control of stress-dependent cardiac growth and gene expression by a microRNA.Science316 , 575–579 (2007).
  • Callis TE , PandyaK, SeokHY et al.: MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.J. Clin. Invest.119 , 2772–2786 (2009).
  • Wang GK , ZhuJQ, ZhangJT et al.: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.Eur. Heart J.31 , 659–666 (2010).
  • Satoh M , MinamiY, TakahashiY, TabuchiT, NakamuraM: Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy.J. Card. Fail.16 , 404–410 (2010).
  • Radom-Aizik S , ZaldivarF Jr, Oliver S, Galassetti P, Cooper DM: Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J. Appl. Physiol.109 , 252–261 (2010).
  • Michiels S , KoscielnyS, HillC: Prediction of cancer outcome with microarrays: a multiple random validation strategy.Lancet365 , 488–492 (2005).
  • Ioannidis JP : Microarrays and molecular research: noise discovery?Lancet365 , 454–455 (2005).
  • Shi L , CampbellG, JonesWD et al.: The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.Nat. Biotechnol.28 , 827–838 (2010).
  • Shi W , BessarabovaM, DosymbekovD et al.: Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.Pharmacogenomics J.10 , 310–323 (2010).
  • Parry RM , JonesW, StokesTH et al.: k-nearest neighbor models for microarray gene expression analysis and clinical outcome prediction.Pharmacogenomics J.10 , 292–309 (2010).
  • Luo J , SchumacherM, SchererA et al.: A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data.Pharmacogenomics J.10 , 278–291 (2010).
  • Oberthuer A , JuraevaD, LiL et al.: Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients.Pharmacogenomics J.10 , 258–266 (2010).
  • Fan X , LobenhoferEK, ChenM et al.: Consistency of predictive signature genes and classifiers generated using different microarray platforms.Pharmacogenomics J.10 , 247–257 (2010).
  • Miclaus K , ChiericiM, LambertC et al.: Variability in GWAS analysis: the impact of genotype calling algorithm inconsistencies.Pharmacogenomics J.10 , 324–335 (2010).
  • Miclaus K , WolfingerR, VegaS et al.: Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K array.Pharmacogenomics J.10 , 336–346 (2010).
  • Zhang L , YinS, MiclausK et al.: Assessment of variability in GWAS with CRLMM genotyping algorithm on WTCCC coronary artery disease.Pharmacogenomics J.10 , 347–354 (2010).
  • Hong H , ShiL, SuZ et al.: Assessing sources of inconsistencies in genotypes and their effects on genome-wide association studies with HapMap samples.Pharmacogenomics J.10 , 364–374 (2010).
  • Chierici M , MiclausK, VegaS, FurlanelloC: An interactive effect of batch size and composition contributes to discordant results in GWAS with the CHIAMO genotyping algorithm.Pharmacogenomics J.10 , 355–363 (2010).
  • Fannin RD , RussoM, O‘ConnellTM et al.: Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation.Hepatology51 , 227–236 (2010).
  • Stamova BS , AppersonM, WalkerWL et al.: Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood.BMC Med. Genomics2 , 49 (2009).
  • Walker WL , LiaoIH, GilbertDL et al.: Empirical Bayes accomodation of batch-effects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients.BMC Genomics9 , 494 (2008).
  • Tillinghast GW : Microarrays in the clinic.Nat. Biotechnol.28 , 810–812 (2010).
  • Baggerly KA , CoombesKR: Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology.Ann. Appl. Stat.3 , 1309–1334 (2009).
  • Goodsaid F , PapalucaM: Evolution of biomarker qualification at the health authorities.Nat. Biotechnol.28 , 441–443 (2010).
  • Goodsaid FM , MendrickDL: Translational medicine and the value of biomarker qualification.Sci. Transl. Med.2(47) , ps44 (2010).
  • Dieterle F , SistareF, GoodsaidF et al.: Renal biomarker qualification submission: a dialog between the FDA–EMEA and Predictive Safety Testing Consortium.Nat. Biotechnol.28 , 455–462 (2010).
  • Mendrick DL : Genomic and genetic biomarkers of toxicity.Toxicology245 , 175–181 (2008).
  • Mattes WB : Public consortium efforts in toxicogenomics. In: Essential Concepts in Toxicogenomics. Mendrick DL, Mattes WB (Eds.). Humana, NJ, USA 221–238 (2008).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.